Transaction Advisory (Corporate)

Corporate M&A and Innovation Strategy


About Cardinal Health


Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally.

For the fiscal year 2017, Cardinal Health reported earnings of US$7.181 billion, with an annual revenue of US$136.809 billion, an increase of 5.3% over the previous fiscal cycle. Cardinal Health's shares traded at over $57 per share, and its market capitalization was valued at over US$15.4 billion in November 2018.As of 2018, Cardinal Health is ranked #14 on the Fortune 500 rankings of the largest United States corporations by total revenue.

It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

The company operates through two segments, Pharmaceutical and Medical.

  • The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. It also provides services to support the development, marketing, and distribution of specialty pharmaceutical products, as well as pharmacy management, and medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; and repackages generic pharmaceuticals and over-the-counter healthcare products.

  • The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products. It also distributes a range of national brand products; and medical products to patients' homes, as well as provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

  • In March 2015, Cardinal Health signed an agreement to acquire Johnson & Johnson's Cordis (medical) division, a cardiology and endovascular device manufacturer, for $1.94 billion.

  • In April 2017, Cardinal Health announced the plan to acquire leading patient product portfolio from Medtronic for $6.1 billion.The acquisition was funded with a combination of $4.5 billion in new senior unsecured notes, existing cash and borrowings under our existing credit arrangements.



    • MedTech Partnering Series




    MedTech Series

    Philips and smith&nephew

    Greenberg Traurig, MassMEDIC and LB Ventures created Medtech Partnering Day

    donwload agenda

    MedTech Series

    Philips

    Law firm Greenberg Traurig, MassMEDIC and LB Ventures created Medtech Partnering Day with an eye on putting start-ups and medtech titans together in the same room.

    MedTech Series

    Smith&Nephew

    Law firm Greenberg Traurig, MassMEDIC and LB Ventures created Medtech Partnering Day with an eye on putting start-ups and medtech titans together in the same room.

    MedTech Series

    Sanofi

    On Thursday, Feb. 11, 2016, Greenberg Traurig LLP’s Global Life Sciences & Medical Technology Group hosted its third MedTech Partnering Day...

    donwload agenda

    MedTech Series

    Covidien (Medtronic)

    This event will connect some of New England’s most innovative emerging medtech companies with strategic partners to maximize opportunities for collaboration, new business development and market expansion...

    donwload agenda

    MedTech Series

    ZOLL (Asahi Kasei)

    This event will connect some of New England’s most innovative emerging medtech companies with strategic partners to maximize opportunities for collaboration, new business development and market expansion.

    donwload agenda

    MedTech Series

    Johnson&Johnson

    On Thursday, Oct. 23, 2014, Greenberg Traurig’s Life Sciences & Medical Technology Group will host its inaugural MedTech Partnering Day

    donwload agenda

    MedTech Series

    Boston Scientific

    On Thursday, Oct. 23, 2014, Greenberg Traurig’s Life Sciences & Medical Technology Group will host its inaugural MedTech Partnering Day

    donwload agenda